Adage Capital Partners’s Sarepta Therapeutics SRPT Stock Holding History

Adage Capital Partners’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-175,000	Closed	-$21.3M	–	934
2024 Q4	$21.3M	Sell	175,000 -100,000	-36%	-$12.2M	0.04%	431
2024 Q3	$34.3M	Sell	275,000 -125,000	-31%	-$15.6M	0.06%	304
2024 Q2	$63.2M	Sell	400,000 -70,000	-15%	-$11.1M	0.12%	182
2024 Q1	$60.8M	Buy	+470,000	New	+$60.8M	0.11%	193
2023 Q4	–	Sell	-560,000	Closed	-$67.9M	–	926
2023 Q3	$67.9M	Sell	560,000 -95,000	-15%	-$11.5M	0.15%	150
2023 Q2	$75M	Buy	655,000 +254,650	+64%	+$29.2M	0.16%	145
2023 Q1	$55.2M	Sell	400,350 -274,650	-41%	-$37.9M	0.12%	192
2022 Q4	$87.5M	Sell	675,000 -210,000	-24%	-$27.2M	0.21%	118
2022 Q3	$97.8M	Sell	885,000 -380,000	-30%	-$42M	0.24%	97
2022 Q2	$94.8M	Buy	1,265,000 +250,000	+25%	+$18.7M	0.22%	99
2022 Q1	$79.3M	Buy	1,015,000 +365,000	+56%	+$28.5M	0.15%	143
2021 Q4	$58.5M	Buy	650,000 +250,000	+63%	+$22.5M	0.11%	194
2021 Q3	$37M	Buy	400,000 +40,247	+11%	+$3.72M	0.07%	273
2021 Q2	$28M	Buy	+359,753	New	+$28M	0.05%	355
2021 Q1	–	Sell	-300,000	Closed	-$51.1M	–	1023
2020 Q4	$51.1M	Sell	300,000 -550,000	-65%	-$93.8M	0.11%	197
2020 Q3	$119M	Sell	850,000 -250,000	-23%	-$35.1M	0.3%	69
2020 Q2	$176M	Sell	1,100,000 -925,000	-46%	-$148M	0.45%	42
2020 Q1	$198M	Buy	2,025,000 +937,670	+86%	+$91.7M	0.59%	25
2019 Q4	$140M	Sell	1,087,330 -637,626	-37%	-$82.3M	0.34%	66
2019 Q3	$130M	Buy	1,724,956 +524,956	+44%	+$39.5M	0.32%	75
2019 Q2	$182M	Sell	1,200,000 -450,000	-27%	-$68.4M	0.45%	49
2019 Q1	$197M	Sell	1,650,000 -700,144	-30%	-$83.5M	0.49%	48
2018 Q4	$256M	Buy	2,350,144 +1,050,144	+81%	+$115M	0.71%	28
2018 Q3	$210M	Buy	1,300,000 +243,389	+23%	+$39.3M	0.47%	46
2018 Q2	$140M	Buy	1,056,611 +956,611	+957%	+$126M	0.32%	74
2018 Q1	$7.41M	Buy	+100,000	New	+$7.41M	0.02%	600